THE Esses Pharmacy (pvt) Ltd Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: THE Esses Pharmacy (pvt) Ltd Pharmaceutical Import Records from India — 3 Products, $923.8K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

THE Esses Pharmacy (pvt) Ltd — Pharmaceutical Importer Profile (2026) | 3 Products, $923.8K Trade | TransData Nexus

THE Esses Pharmacy (pvt) Ltd

Pharmaceutical Importer · Sri Lanka · Oncology Focus · $923.8K Total Trade · DGFT Verified

THE Esses Pharmacy (pvt) Ltd is a pharmaceutical importer based in Sri Lanka with a total trade value of $923.8K across 3 products in 2 therapeutic categories. Based on 30 verified import shipments from Indian Customs (DGFT) records, THE Esses Pharmacy (pvt) Ltd is the #1 buyer in 1 product including Lomustine. THE Esses Pharmacy (pvt) Ltd sources from 1 verified Indian supplier, with Pleasant Exports accounting for 100.0% of imports.

THE Esses Pharmacy (pvt) Ltd — Import Portfolio & Supplier Network

THE Esses Pharmacy (pvt) Ltd import network — 3 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to THE Esses Pharmacy (pvt) Ltd?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Pleasant Exports	$130.5K	215	100.0%

THE Esses Pharmacy (pvt) Ltd sources from 1 verified Indian supplier across 149 distinct formulations. The sourcing is highly concentrated — Pleasant Exports accounts for 100.0% of total imports, indicating a strategic single-source relationship.

What Formulations Does THE Esses Pharmacy (pvt) Ltd Import?

Formulation	Value	Ships
Krabeva 400 INJ bevacizumab 400 MG	$12.9K	2
Krabeva 100 INJ bevacizumab 100 MG	$10.6K	2
Carboplatin 450 INJ carboplatin 450 MG	$6.1K	2
Thymoglobuline INJ immunoglobulnrab 25 MG	$4.8K	2
Biotrexate INJ methotrexate 500 MG	$4.3K	2
Veenat 400 TAB imatinib 400 MG	$2.8K	1
Votrient TAB pazopamib 400 MG	$2.5K	4
Atrapure INJ atracurium 25 MG	$2.4K	3
Adriamycin rtu INJ doxorubicin 50 MG	$2.3K	1
Mito INJ mitomycin 40 MG	$2.3K	2
Taxotere 80 INJ docetaxel 80 MG	$2.0K	2
Emeset INJ ondansetron 8 MG	$2.0K	2
Kemocarb INJ carboplatin 450 MG	$1.8K	1
Gutron TAB midodrine 2.5 MG	$1.8K	2
Gemcite 1000 INJ gemcitabine 1 GM	$1.7K	1

Import Portfolio — Top 3 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Carboplatin	Oncology	$900.0K	18	1.3%	9
2	Thalidomide	Advanced Oncology	$13.6K	9	0.7%	11
3	Lomustine	Advanced Oncology	$10.3K	3	9.9%	1

THE Esses Pharmacy (pvt) Ltd imports 3 pharmaceutical products across 2 categories into Sri Lanka totaling $923.8K. The company is the #1 buyer for 1 product: Lomustine.

THE Esses Pharmacy (pvt) Ltd — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

THE Esses Pharmacy (Pvt) Ltd is a pharmaceutical importer and distributor based in Colombo, Sri Lanka. Specializing in the importation of finished pharmaceutical formulations, the company plays a pivotal role in supplying critical medications to the Sri Lankan market. Their primary focus is on oncology treatments, ensuring the availability of essential cancer therapies within the country.

The company's headquarters are located at No. 343 Galle Road, Bambalapitiya, Colombo 04, Sri Lanka. This strategic location positions them centrally within Colombo, facilitating efficient distribution and accessibility. While specific information regarding a parent company is not readily available, THE Esses Pharmacy (Pvt) Ltd operates as an independent entity, dedicated to meeting the pharmaceutical needs of the Sri Lankan population.

2Distribution Network

THE Esses Pharmacy (Pvt) Ltd maintains a centralized distribution model from their Colombo headquarters. This approach enables them to effectively manage inventory and coordinate logistics for nationwide distribution. While detailed information about additional warehouse locations or logistics capabilities is not specified, their strategic position in Colombo suggests a focus on optimizing supply chain operations to meet the demands of the Sri Lankan market.

3Industry Role

In Sri Lanka's pharmaceutical supply chain, THE Esses Pharmacy (Pvt) Ltd functions primarily as a pharmaceutical importer and distributor. By sourcing finished pharmaceutical formulations from international suppliers, they ensure the availability of essential medications, particularly in the oncology sector. Their role is crucial in bridging the gap between global pharmaceutical manufacturers and the local healthcare system, facilitating access to life-saving treatments for patients across Sri Lanka.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — THE Esses Pharmacy (pvt) Ltd

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

THE Esses Pharmacy (Pvt) Ltd exhibits a high degree of supplier concentration, sourcing all their imported pharmaceutical formulations from a single supplier, PLEASANT EXPORTS. This exclusive sourcing strategy, with a total import value of $924K USD across 30 shipments, indicates a strong and stable relationship between the two entities. However, such dependency on a single supplier may pose risks, including potential supply chain disruptions or pricing fluctuations. The consistent volume of imports suggests a mutually beneficial partnership, yet it also underscores the importance of evaluating and mitigating risks associated with supplier concentration.

2Supply Chain Resilience

The resilience of THE Esses Pharmacy (Pvt) Ltd's supply chain is closely tied to their exclusive relationship with PLEASANT EXPORTS. While this partnership ensures a steady supply of pharmaceutical formulations, the lack of alternative suppliers may expose the company to risks such as supply interruptions or regulatory changes affecting their sole supplier. The diversity of formulations imported, with 149 unique products, indicates a broad portfolio, which can help mitigate some risks. However, the absence of backup suppliers and potential exposure to shipping route disruptions highlight areas where the company's supply chain resilience could be enhanced.

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

The National Medicines Regulatory Authority (NMRA) is the primary regulatory body overseeing the pharmaceutical sector in Sri Lanka. Established in 2015 through an Act of Parliament, the NMRA is responsible for ensuring the safety, efficacy, and quality of medicines, medical devices, and related products within the country. The NMRA regulates the manufacturing, importation, distribution, and sale of medicines, playing a crucial role in protecting public health by enforcing standards and guidelines for pharmaceutical products. (nmra.gov.lk)

2Import Licensing & GMP

Import licensing in Sri Lanka is managed by the NMRA, which requires all pharmaceutical products to be registered before they can be imported and marketed. This process ensures that imported medicines meet the necessary safety, efficacy, and quality standards. The NMRA recognizes Good Manufacturing Practice (GMP) certifications from reputable authorities, including the World Health Organization (WHO) and the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Indian exporters seeking to supply THE Esses Pharmacy (Pvt) Ltd must ensure that their manufacturing facilities hold valid GMP certifications recognized by the NMRA to comply with import regulations. (nmra.gov.lk)

Quality & Labeling

THE Esses Pharmacy (pvt) Ltd — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

THE Esses Pharmacy (Pvt) Ltd's focus on oncology products, particularly carboplatin, thalidomide, and lomustine, aligns with the significant demand for cancer treatments in Sri Lanka. The high import value of carboplatin ($900K) and the substantial market share of lomustine (9.9%) indicate a strategic emphasis on these critical therapies. This product strategy is driven by the pressing need for effective cancer treatments in the region, positioning THE Esses Pharmacy (Pvt) Ltd as a key supplier in this therapeutic area.

2Sourcing Profile

THE Esses Pharmacy (Pvt) Ltd's sourcing strategy is heavily reliant on a single supplier, PLEASANT EXPORTS, for their pharmaceutical formulations. This approach suggests a preference for consistent product quality and supply reliability. The exclusive sourcing from India indicates a strategic choice to leverage the country's established pharmaceutical manufacturing capabilities and cost advantages. However, this concentration also exposes the company to potential risks associated with single-source dependency.

3Market Positioning

By focusing on high-value oncology products, THE Esses Pharmacy (Pvt) Ltd serves a niche segment of the Sri Lankan pharmaceutical market. Their role as a primary importer and distributor of critical cancer therapies positions them as a vital partner for hospitals, oncology clinics, and healthcare providers requiring specialized medications. This market positioning underscores their commitment to addressing the specific needs of cancer patients in Sri Lanka.

Seller's Guide — How to Become a Supplier to THE Esses Pharmacy (pvt) Ltd

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

For new Indian suppliers, there is a realistic opportunity to engage with THE Esses Pharmacy (Pvt) Ltd by offering alternative products or formulations not currently supplied by PLEASANT EXPORTS. Identifying gaps in THE Esses Pharmacy (Pvt) Ltd's current sourcing, such as additional oncology treatments or other therapeutic areas, could present avenues for collaboration. Establishing a relationship would require demonstrating product quality, compliance with NMRA regulations, and the ability to meet the company's supply chain requirements.

2Requirements & Qualifications

Indian exporters aiming to supply THE Esses Pharmacy (Pvt) Ltd must ensure that their manufacturing facilities hold valid GMP certifications recognized by the NMRA, such as WHO GMP or PIC/S certifications. Products must be registered with the NMRA, adhering to the necessary safety, efficacy, and quality standards. Additionally, compliance with labeling requirements, including information in English and Sinhala, and adherence to serialization mandates are essential for market entry. (nmra.gov.lk)

3How to Approach

Frequently Asked Questions — THE Esses Pharmacy (pvt) Ltd

What products does THE Esses Pharmacy (pvt) Ltd import from India?

THE Esses Pharmacy (pvt) Ltd imports 3 pharmaceutical products across 2 categories. Top imports: Carboplatin ($900.0K), Thalidomide ($13.6K), Lomustine ($10.3K).

Who supplies pharmaceuticals to THE Esses Pharmacy (pvt) Ltd from India?

THE Esses Pharmacy (pvt) Ltd sources from 1 verified Indian suppliers. The primary supplier is Pleasant Exports (100.0% of imports, $130.5K).

What is THE Esses Pharmacy (pvt) Ltd's total pharmaceutical import value?

THE Esses Pharmacy (pvt) Ltd's total pharmaceutical import value from India is $923.8K, based on 30 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does THE Esses Pharmacy (pvt) Ltd focus on?

THE Esses Pharmacy (pvt) Ltd imports across 2 categories. The largest: Oncology (97.4%), Advanced Oncology (2.6%).

Get Full THE Esses Pharmacy (pvt) Ltd Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.